Why the study?
To outline the state-of-the-art of cardiac 123I-mIBG imaging and define its value and clinical applications across different fields of cardiovascular diseases.
This expert consensus document provides state-of-the-art guidance on the clinical applications and prognostic value of cardiac 123I-mIBG imaging in cardiovascular diseases.
Supports 123I-mIBG integration for cardiovascular risk stratification; extends evidence with standardized expert consensus on applications.
Cardiac sympathetic activity plays a key role in supporting cardiac function in both health and disease conditions, and nuclear cardiac imaging has always represented the only way for the non-invasive evaluation of the functional integrity of cardiac sympathetic terminals, mainly through the use of radiopharmaceuticals that are analogues of norepinephrine and, in particular, with the use of 123I-mIBG imaging. This technique demonstrates the presence of cardiac sympathetic dysfunction in different cardiac pathologies, linking the severity of sympathetic nervous system impairment to adverse patient's prognosis. This article will outline the state-of-the-art of cardiac 123I-mIBG imaging and define the value and clinical applications in the different fields of cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Gimelli et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: